Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
boston blog main
clinical trials
fda
national top stories
san francisco blog main
san francisco top stories
abcellera
aligos therapeutics
ame cloud ventures
american diabetes association
antibodies
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
boston
boston top stories
cavion
cephalgia
chronic hepatitis b virus
clostridium difficile
colleen cutcliffe
computational biology
coronavirus
covid-19
david goldstein
demodex blepharitis
depression
diabetes type 2
drug discovery
eli lilly
epilepsy
essential tremor
eventide asset management
hepatitis b
horowitz group
What
leads
3
×
medicines
abcellera
abcellera’s
antibodies
antibody
available
balance
based
biologics
biome
biotech
biotechs
blood
central
cns
coronavirus
diabetes
disorder
drugs
emerged
enter
eyes
food
healthy
hormone
identified
include
intended
ipos
kept
launch
levels
medical
nervous
neutralizing
pills
potentially
praxis
precision
Language
unset
Current search:
biotech
×
leads
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
